|
The Clinical Advisory Board will also advise Onconova on other drug
candidates being developed by the Company. These include ON 01210, Ex-RAD(TM),
for protection from whole-body radiation, being developed in partnership with
the Armed Forces Radiobiology Research Institute (AFRRI); an
advanced preclinical stage compound targeting BCR-ABL involved in Chronic
Myelogenous Leukemia (CML). A key attribute of this inhibitor is its potent
activity against all mutant forms of BCR-ABL kinase found in drug-resistant
CML. The Company also has a strong pipeline of specific enzyme
inhibitors, applicable for cancer, autoimmune, ophthalmic, and central nervous
system indications, in earlier stages of development.
New! Sign up for local CML support group meetings in your local community at http://cml.meetup.com Apply for Commercial Real Estate loans online and submit your deal to dozens of hungry lenders in just minutes. Loan programs for all types of business and commercial real estate. Apply anytime at http://realestatezoo.com CML (Chronic Myelogenous Leukemia Support List) --------------------------------- Part Of CMLHope.Com An International Community Of CML Patients For more information: http://cmlhope.com Post Message: [email protected] Subscribe: [EMAIL PROTECTED] Unsubscribe: [EMAIL PROTECTED] Change To No Mail/Web: [EMAIL PROTECTED] Change To Digest: [EMAIL PROTECTED] Change To Email: [EMAIL PROTECTED] List Help: [EMAIL PROTECTED] CML Group Web Site http://groups.yahoo.com/group/CML
Yahoo! Groups Links
|
